20-12-2022 03:00 via wallstreet-online.de

Kazia Therapeutics (KZIA): Collaboration May Expand Utility to Combo Therapies

LONDON, UK / ACCESSWRE / December 19, 2022 / Kazia Therapeutics has announced a research collaboration with QIMR Berghofer Medical Research Institute (an Australia-based cancer research center) to investigate the utility of its lead asset, paxalisib …
Weiterlesen »